Toxicology
Invitek offers non-GLP toxicology studies. Non-GLP toxicity studies intended to provide a preliminary assessment of a drug’s safety.
Non-GLP tox studies have the following advantage:
- Performed on research grade materials
- Gives the flexibility to design study protocol for regulatory submission
- Reduces costs and time required for GMP grade material
GLP toxicology studies are required as part of the IND package before starting a human clinical trial.
In-Vivo Services
Route of Administration
Following standard routes of administration are offered
- Oral (PO)
- Intraperitoneal (IP)
- Subcutaneous (SC)
- Intravenous (IV)
- Intramuscular (IM)
- Topical
Toxicity Services
- Maximum Tolerated Dose (MTD)
- Acute Single Dose Toxicity
- Repeat Dose Toxicity
- Sub-Chronic Toxicity
- Chronic Toxicity
- Toxicokinetic
Genotoxicity
- Bacterial Reverse Mutation (Ames) study
- Chromosomal Aberration study
- Mouse Micronucleus study
In-Vitro Services
- Cytotoxicity
- MTT Assays
